GrowForce Portfolio

Currently, the GrowForce Portfolio includes 17,000 kilograms of owned and fully funded production capacity.

GrowForce AMI

Ownership: 50%

AMI is a state-of-the-art cultivation facility that will produce high quality and high yield cannabis with eventual extraction operations for the expansive Canadian market.

Located in Lower Sackville, Nova Scotia, GrowForce AMI is acting under the authority of Health Canada’s Cannabis Act (formerly known as the Access to Cannabis for Medical Purposes Regulation (ACMPR).

Size: 48,000 sq. ft. facility

Type: Cultivation Facility

Anticipated Yearly Production: 6,000,000 g


will.gif

GROWFORCE WILL

Ownership: 100%

WILL is a leading-edge facility located producing high quality, high yield cannabis for the Canadian market.

Located in Brampton, Ontario, WILL is currently licensed to cultivate medical marijuana, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR).

Size: 32,500 Sq. Ft. plus facility expansion in development

Type: Cultivation Facility

Anticipated Yearly Production: 3,000,000 Grams with additional capacity expansion to 5,000,000 Grams.

war.gif

GROWFORCE WPG

Ownership: 100%

WPG will be a state-of-the-art cultivation powerhouse, producing high quality and high yield cannabis for the expansive Canadian market.

Located in Winnipeg, Manitoba, GrowForce WPG intends to house a second site license under GrowForce WILL, licensed to cultivate medical marijuana, acting under the authority of a license issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (ACMPR).

Size: 120,000 sq. ft. facility on 13-acres of land for development

Type: Cultivation Facility

Anticipated Yearly Production: 10,800,000 Grams

gro.gif

GROWFORCE GRO

Ownership: 51%

Grand River Organics will be a craft grower of premium cannabis in the Niagara Peninsula.

Located in Dunnville, Ontario, GRO is a late-stage applicant under the Access to Cannabis for Medical Purposes Regulation (ACMPR).

Size: 10,800 Sq. Ft.

Type: Cultivation Facility

Anticipated Yearly Production: 1,050,000 Grams